THE INFLUENCE OF TAURINE-CONTAINING MEDICINE «KRATAL» ON METABOLIC SYNDROME DEVELOPMENT INDUCED BY HIGH FAT DIET

Authors

  • Zvyagina T. S. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv
  • Gorbenko N. I. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv https://orcid.org/0000-0001-6598-730X
  • Borikov A. Yu. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv https://orcid.org/0000-0001-5776-566X
  • Shalamay A. S. Borshchagivsky Chemical-Pharmaceutical Plant, Kyiv

DOI:

https://doi.org/10.21856/j-PEP.2013.2.11

Keywords:

high fat diet, experimental metabolic syndrome, taurine, Kratal

Abstract

It has been established that taurine-containing preparation «Kratal» suppresses development
of insulin-resistance, glucose intolerance, abdominal obesity, hypertriglyceridemia, oxidative stress
and endothelial dysfunction. In male-rats with insulin-resistance induced by high fat diet finding
results have been based expediency of widening of spectrum of preparation «Kratal» application
for cardiovascular pathologies attenuation under metabolic syndrome conditions and type 2 diabetes
mellitus prophylaxis in persons from risk group.

References

Misra A, Misra A, Singhal N, Khurana L. J Amer Colledge Nutr 2010; 29(3):289S-301S.

Zachary T. Diabetes Care 2005; 28:2073-2080.

Kalupahana NS, Claycombe KJ, Moustaid-Moussa N. Adv Nutr 2011; 2:304-316.

Martins AR, Nachbar RT, Gorjao R, et al. Lipids Hlth Dis 2012; 11(30), available at: http://www.lipidworld.com /content/11/1/30.

Abebe W, Mozaffari MS. Amer J Cardiovasc Dis 2011; 1(3):293-311.

Song S, et al. Amer J Physiol Endocrinol Metabol 2001; 281(2):E275-282.

Arutyunyan AV, et al. Cankt-Peterburg, 2000:104 p.

Akinmokun A, Selby PL, Ramaiya K, Alberti KG. Diabet Med 1992; 9(4):432-437.

Sovremennye metody v biokhimii, pod red. Orekhovicha VN, Moskva, 1977:392 p.

Volchegorskiy IA, et al. Voprosy med. khimii 1989; 1:127-131.

Stal’naya ID,Garishvili GL. Sovremennye metody v biokhimii 1977:66-68.

Opredeleniya soderzhaniya vostanovlenogo glutationa v tkanyakh. Metody biokhimicheskikh issledovaniy (lipidnyy i energeneticheskiy obmen), pod red. M. I. Prokhorovoy, Leningrad, 1982:183-187.

Orlova EA. Ukr zhurn eksperim meditsiny 2002; 3(1):79-82.

Prokhorova MI, Tupikova ZN, Leningrad, 1965:218 p.

Men’shikov VV, Delektorskaya LN, Zolotnitskaya RP, pod red. Men’shikova VV, Moskva, 1987:365 p.

Fletcher MJ. Clin Acta 1969; 22(3):393-397.

Miller GL. Analyt Chem 1959; 31(5):964-966.

Glans S, Moskva,1998:459 p.

Misra A, Khurana l. J Clin Endocrinol Metab 2008; 93(11):S9-S30.

Poornima I, Parikh P, Shannon R. Circ Res 2006; 98:596-605.

Yang N, Ying C, Xu M, et al. Cardiovasc Res 2007; 76:167-174.

Pacher P, Beckman JS, Liaudet L. Physiol Rev 2007; 87:315-424.

Koh1 KK. Oh1 PC, Quon MJ. Cardiovasc Res 2009; 81:649-659.

Downloads

Published

2013-06-18

How to Cite

Zvyagina, T. S., Gorbenko, N., Borikov, O., & Shalamay, A. S. (2013). THE INFLUENCE OF TAURINE-CONTAINING MEDICINE «KRATAL» ON METABOLIC SYNDROME DEVELOPMENT INDUCED BY HIGH FAT DIET. Problems of Endocrine Pathology, 44(2), 67-73. https://doi.org/10.21856/j-PEP.2013.2.11

Most read articles by the same author(s)

1 2 > >>